Vaxcyte Cash Flow Statement
NASDAQ: PCVXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
71.38+6.37 (+9.79%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Vaxcyte free cash flow
In fiscal 2025, Vaxcyte generated -$655.6 million of operating cash flow and spent $13.7 million on capital expenditures. That left free cash flow of -$669.3 million.
Summary generated from market data by MetaCap's automated system. Methodology
Vaxcyte cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -766.63M | -463.93M | -402.27M | -223.49M | -100.08M | -89.22M | -50.27M | -29.48M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 16.40M | 7.00M | 3.16M | 2.83M | 1.80M | 1.41M | 1.23M | 1.04M |
| Stock-Based Compensation | 138.84M | 84.82M | 48.76M | 23.65M | 10.73M | 5.43M | 1.19M | 749.00K |
| Change in Working Capital | -14.01M | -27.58M | 14.51M | 9.60M | -11.38M | 28.23M | 1.71M | 927.00K |
| Operating Cash Flow | -655.58M | -452.63M | -296.79M | -170.60M | -121.39M | -46.63M | -47.15M | -30.47M |
| Capital Expenditures | -13.71M | -22.43M | -16.06M | -5.84M | -6.55M | -1.16M | -1.20M | -1.77M |
| Investing Cash Flow | 437.35M | -2.01B | -773.31M | 74.58M | -212.31M | -1.10M | -1.20M | -1.77M |
| Financing Cash Flow | 2.01M | 2.45B | 639.81M | 861.55M | 17.80M | 374.87M | 41.57M | 62.19M |
| Net Change in Cash | -213.77M | -9.36M | -436.97M | 765.67M | -316.34M | 327.22M | -7.11M | 29.95M |
| Free Cash Flow | -669.29M | -475.05M | -312.85M | -176.44M | -127.95M | -47.78M | -48.34M | -32.24M |
This table shows 8 annual periods of Vaxcyte's cash flow statement, from FY 2025 back to FY 2018, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow PCVX's reporting calendar. What is a cash flow statement?